Efficacy of RADA16-Based Self-Assembling Peptides on Wound Healing: A Meta-Analysis of Preclinical Animal Studies
Pharmaceuticals · 03.04.2025 · 18 (4) · 526
DOI: 10.3390/ph18040526 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Pharmaceuticals, online erschienen am 03.04.2025. Verfasst von Jiaju Lu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bioactive Materials, Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai Un…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Objectives
This analysis aims to provide evidence supporting the feasibility of clinical application of self-assembling peptides for skin wound healing.
Methods
This review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. PubMed, Web of Science, and Cochrane Library were searched (up to June 17, 2024). The primary outcome, wound closure rate at 7 and 14 days post-injury, was pooled using a random-effects meta-analysis. The risk of bias (ROB) assessment and meta-analysis were performed using the Systematic Review Centre for Laboratory animal Experimentation (SYRCLE)’s ROB tool for animal studies and RevMan software.
Results
A total of 502 unique records were identified from our search, with 12 experimental animal studies meeting the prespecified inclusion criteria (n = 272 animals). The RADA16 interventions promoted wound closure rate compared to controls (saline or no treatment group) in both diabetic and non-diabetic animal models (Mean Difference (MD) = 11.25, 95% Confidence Interval (CI): 5.73 to 16.78, p < 0.0001; MD = 9.48, 95% CI: 4.75 to 14.22, p < 0.0001 at 7 and 14 days post-injury, respectively). Healing was further enhanced using RADA16-based functional self-assembling peptides compared to RADA16 group in both diabetic and non-diabetic animal models (MD = 27.25, 95% CI: 22.68 to 31.83, p < 0.00001; MD = 29.11, 95% CI: 24.30 to 33.91, p < 0.00001 at 7 and 14 days after injury, respectively). The ROB was uncertain for most studies due to insufficient reporting.
Conclusions
RADA16-based self-assembling peptides, particularly those modified with functional peptide motifs, represent a promising treatment for non-diabetic and diabetic wounds in pre-clinical studies, and translation to the clinical domain appears warranted.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Bioactive Materials, Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin 300071, China.
- School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China.
ORCID-Profile: Zeyue Sun
Zitieren
APA
Lu, J., Chen, L., Sun, Z., & Yang, Z. (2025). Efficacy of RADA16-Based Self-Assembling Peptides on Wound Healing: A Meta-Analysis of Preclinical Animal Studies. Pharmaceuticals, 18(4), 526. https://doi.org/10.3390/ph18040526
Vancouver
Lu J, Chen L, Sun Z, Yang Z. Efficacy of RADA16-Based Self-Assembling Peptides on Wound Healing: A Meta-Analysis of Preclinical Animal Studies. Pharmaceuticals. 2025;18(4):526. doi:10.3390/ph18040526
BibTeX
@article{Lu2025,
author = {Lu, Jiaju and Chen, Liuting and Sun, Zeyue and Yang, Zhimou},
title = {Efficacy of RADA16-Based Self-Assembling Peptides on Wound Healing: A Meta-Analysis of Preclinical Animal Studies},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {4},
pages = {526},
doi = {10.3390/ph18040526}
}
EUVIMED